Tareq Affouri

Barrington Research reassumed coverage of DENTSPLY International Inc. (NASDAQ: XRAY), after an analyst transition. Michael Petusky and Tareq Affouri are now responsible for coverage and they issued a Market Perform rating. The firm had last rated it at Outperform (May 2014). Although DENTSPLY...

Barrington Research initiated coverage on PharMerica Corporation (NYSE: PMC) Thursday with an Outperform rating and $30 price target. Analysts Michael Petusky and Tareq Affouri noted that the company is well positioned to benefit from several macro-related tailwinds "...including “...